Clinical trial
Visual Performance of Patients With Either Bilateral Implantation of the ZEISS AT LARA or the ZEISS AT LARA in One Eye and ZEISS AT LISA Tri in the Other (Presbyopia IOL Concept Evaluation).
NCT05462067 is registered in ClinicalTrials.gov with Carl Zeiss Meditec AG as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Visual Performance of Patients With Either Bilateral Implantation of the ZEISS AT LARA or the ZEISS AT LARA in One Eye and ZEISS AT LISA Tri in the Other (Presbyopia IOL Concept Evaluation).
- Lead sponsor
- Carl Zeiss Meditec AG
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- March 14, 2019
- Completion date
- November 20, 2020
- Enrollment
- 72 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.